Pro D3

How to order Pro D3

1. Find the drug you need on our site.
2. Pick a clinic. See the price.
3. Fill in a short health form.
4. A doctor reads your form.
5. If it is safe for you, they say yes.
6. Your order ships fast to your door.
7. It comes in a plain, sealed box.

Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.

Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.

Pro D3 on Prescriptsy

Pro D3 is described on Prescriptsy as independent product information.

Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.

We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.

Pro D3 is a UK-licensed colecalciferol (vitamin D3) supplement available as soft capsules in multiple strengths, including 400 IU (10 micrograms), 2000 IU (50 micrograms), 3200 IU (80 micrograms), and 20,000 IU (500 micrograms).

It is prescribed for the prevention and treatment of vitamin D deficiency in adults and children.

Vitamin D is a fat-soluble secosteroid prohormone that plays a critical role in calcium and phosphate homeostasis, bone mineralisation, muscle function, and immune regulation.

Insufficient vitamin D levels are widespread in the United Kingdom, particularly during autumn and winter when UVB sunlight is too weak for cutaneous synthesis.

Vitamin D deficiency affects an estimated one in five adults and one in five children in the UK.

It is a significant public health concern because prolonged deficiency leads to rickets in children, osteomalacia in adults, and contributes to osteoporosis and increased fracture risk in older adults.

This page provides a comprehensive clinical overview of Pro D3, including how vitamin D works, who needs supplementation, correct dosing, side effects, safety warnings, and how to obtain a prescription in the UK.

Important safety information about Pro D3

Before reading further, note the following key safety points about Pro D3.

• Do not exceed the dose prescribed by your clinician. Excessive vitamin D intake over prolonged periods can cause hypercalcaemia and vitamin D toxicity.
• If you have sarcoidosis, other granulomatous disease, or lymphoma, use vitamin D supplements only under medical supervision due to the increased risk of hypercalcaemia.
• Tell your prescriber about all other medications you take, including thiazide diuretics, cardiac glycosides, calcium supplements, and any other vitamin D products.
• Take Pro D3 with food containing fat to optimise absorption.

What is vitamin D and why is it important

Vitamin D is a group of fat-soluble secosteroids essential for calcium and phosphate absorption, bone health, and numerous physiological processes.

There are two main forms: vitamin D3 (colecalciferol), which is produced in the skin upon UVB exposure and found in animal-derived foods, and vitamin D2 (ergocalciferol), which is found in certain fungi and plant sources.

Vitamin D3 is the preferred supplementation form because it raises serum 25-hydroxyvitamin D (25(OH)D) more effectively and sustainably than D2.

Once in the body, vitamin D3 undergoes two hydroxylation steps to become biologically active.

The first occurs in the liver, producing 25-hydroxyvitamin D (calcidiol), the main circulating form measured in blood tests.

The second occurs primarily in the kidneys, producing 1,25-dihydroxyvitamin D (calcitriol), the active hormonal form.

Calcitriol binds to the vitamin D receptor (VDR), a nuclear transcription factor expressed in almost every tissue in the body.

In the intestine, it promotes the absorption of dietary calcium and phosphate. In bone, it regulates osteoblast and osteoclast activity to maintain mineral balance.

It also modulates parathyroid hormone (PTH) secretion, immune cell differentiation, and cell proliferation.

Vitamin D deficiency in the United Kingdom

The UK lies between latitudes 50 and 60 degrees north, where UVB radiation is insufficient for cutaneous vitamin D synthesis from approximately October to March.

The National Diet and Nutrition Survey (NDNS) consistently shows that a significant proportion of the UK population has serum 25(OH)D levels below the threshold for adequacy.

Approximately 1 in 5 adults and 1 in 5 children in England have serum 25(OH)D below 25 nmol/L, the level at which deficiency is diagnosed.

Population groups at particular risk include people who spend very little time outdoors (care home residents, office workers, housebound individuals), those who cover most of their skin for cultural or religious reasons, people with darker skin pigmentation (who require longer UVB exposure to produce equivalent vitamin D), older adults (whose skin synthesises vitamin D less efficiently), pregnant and breastfeeding women, people with obesity (vitamin D is sequestered in adipose tissue), and individuals with malabsorption conditions such as coeliac disease, Crohn's disease, ulcerative colitis, or previous bariatric surgery.

Consequences of vitamin D deficiency

Severe and prolonged vitamin D deficiency causes rickets in children (characterised by soft, weak bones, bowing of the legs, delayed growth, and dental problems) and osteomalacia in adults (characterised by diffuse bone pain, proximal muscle weakness, and pathological fractures).

Milder deficiency contributes to reduced bone mineral density (osteopenia and osteoporosis), increased risk of fragility fractures, muscle weakness, fatigue, and low mood.

Emerging research also suggests associations between low vitamin D status and cardiovascular disease, type 2 diabetes, autoimmune conditions, and certain cancers, although causation has not been firmly established in all cases.

How Pro D3 works: mechanism of action

Pro D3 capsules deliver colecalciferol (vitamin D3) in an oil-based formulation to optimise absorption from the gastrointestinal tract.

As a fat-soluble vitamin, colecalciferol is absorbed alongside dietary lipids via chylomicrons in the small intestine.

It is then transported to the liver, where hepatic 25-hydroxylase (CYP2R1) converts it to 25-hydroxyvitamin D (calcidiol).

Calcidiol circulates bound to vitamin D-binding protein (DBP) and has a half-life of approximately 2 to 3 weeks, making it the best marker of overall vitamin D status.

In the kidneys, the enzyme 1-alpha-hydroxylase (CYP27B1) converts calcidiol to 1,25-dihydroxyvitamin D (calcitriol).

This conversion is tightly regulated by serum calcium, phosphate, PTH, and fibroblast growth factor 23 (FGF-23).

Calcitriol exerts its biological effects by binding to the intracellular VDR, forming a heterodimer with the retinoid X receptor (RXR), and modulating the transcription of over 200 genes involved in calcium transport, bone remodelling, cell differentiation, immune modulation, and glucose metabolism.

The primary physiological actions of active vitamin D include increasing intestinal calcium absorption (from approximately 10 to 15% without vitamin D to 30 to 40% with adequate levels), promoting renal calcium reabsorption, suppressing PTH secretion to prevent secondary hyperparathyroidism, and supporting osteoblast-mediated bone formation.

These actions collectively maintain serum calcium within the narrow physiological range required for nerve conduction, muscle contraction, and cardiac function.

UK guidelines for vitamin D supplementation

Several authoritative bodies have published guidance on vitamin D supplementation in the UK.

SACN and PHE recommendations

The Scientific Advisory Committee on Nutrition (SACN) published its landmark report on vitamin D and health in 2016, recommending a Reference Nutrient Intake (RNI) of 400 IU (10 micrograms) per day for the general population aged 4 years and over throughout the year.

For infants and children aged 1 to 4 years, 400 IU daily is recommended.

Exclusively and partially breastfed infants from birth should receive 340 to 400 IU (8.5 to 10 micrograms) daily.

Public Health England (now the Office for Health Improvement and Disparities, OHID) endorses these recommendations.

NICE Clinical Knowledge Summary

The NICE CKS on vitamin D deficiency in adults provides practical guidance for primary care.

It recommends a loading regimen of approximately 300,000 IU in total, given as divided doses over 6 to 10 weeks, for patients with confirmed deficiency (25(OH)D below 25 nmol/L).

This is followed by lifelong maintenance therapy of 800 to 2000 IU daily.

The CKS advises checking serum calcium before starting treatment and repeating the 25(OH)D measurement approximately 3 months after completing the loading phase to confirm adequacy.

Royal Osteoporosis Society

The Royal Osteoporosis Society recommends 400 IU daily for the general adult population and 800 to 1000 IU daily for people at increased risk of vitamin D deficiency or those with osteoporosis.

It emphasises the importance of adequate vitamin D for calcium absorption and fracture prevention, particularly in older adults who are at higher risk of falls and fractures.

Dosage and administration of Pro D3

Pro D3 is available in capsule strengths suited to both loading and maintenance therapy.

The 20,000 IU capsule is typically used for loading dose regimens, while the 800 IU, 2000 IU, and 3200 IU capsules are used for ongoing maintenance.

The exact dose and duration should be determined by your prescriber based on your blood test results and individual risk factors.

Loading dose for confirmed deficiency

For adults with serum 25(OH)D below 25 nmol/L, a commonly used regimen is Pro D3 20,000 IU capsules taken twice weekly for 7 weeks (total approximately 280,000 IU).

Alternatively, 40,000 IU weekly for 7 weeks may be prescribed. The loading phase aims to rapidly replenish depleted stores and normalise serum 25(OH)D.

Obese patients or those with malabsorption may require higher loading doses under specialist supervision.

Maintenance therapy

After completing the loading phase, maintenance doses of 800 to 2000 IU daily are recommended indefinitely, particularly for individuals with ongoing risk factors for deficiency.

Pro D3 2000 IU or 3200 IU capsules taken daily or on alternate days are suitable options. Your GP may adjust the dose based on follow-up blood tests.

Administration advice

Pro D3 capsules should be swallowed whole with water, taken with a main meal containing dietary fat to enhance absorption. Capsules should not be chewed or crushed.

If you miss a dose, take it when you remember unless the next dose is due soon. Do not double up on doses.

Side effects of Pro D3

Common considerations

At recommended doses, Pro D3 is very well tolerated and side effects are uncommon. Mild gastrointestinal symptoms such as nausea or abdominal discomfort have been reported rarely.

Hypercalcaemia

The principal risk of vitamin D supplementation is hypercalcaemia, which may occur with excessive dosing or in patients with conditions that increase sensitivity to vitamin D (such as sarcoidosis, lymphoma, or primary hyperparathyroidism).

Symptoms include nausea, vomiting, loss of appetite, excessive thirst, frequent urination, constipation, headache, confusion, drowsiness, and muscle weakness.

If untreated, sustained hypercalcaemia can lead to nephrocalcinosis (calcium deposits in the kidneys), kidney stones, renal impairment, and cardiac arrhythmias.

Contact your GP immediately if you develop any of these symptoms while taking Pro D3.

When to seek medical advice

Seek medical advice if you experience persistent nausea, vomiting, excessive thirst, frequent urination, confusion, or muscle weakness while taking Pro D3. These may indicate hypercalcaemia.

Also seek advice for any signs of an allergic reaction such as rash, itching, swelling, or difficulty breathing.

Report any suspected adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .

Warnings and precautions

Contraindications

Pro D3 is contraindicated in patients with hypercalcaemia, hypercalciuria, nephrolithiasis (kidney stones composed of calcium), and existing hypervitaminosis D. It should not be used in patients with known hypersensitivity to colecalciferol or any excipient.

Granulomatous diseases

Patients with sarcoidosis, tuberculosis, histoplasmosis, berylliosis, or other granulomatous conditions and lymphoma are at increased risk of hypercalcaemia because activated macrophages in granulomata produce calcitriol independently of renal regulation.

These patients should only take vitamin D under close medical supervision with regular monitoring of serum calcium.

Renal impairment

Patients with chronic kidney disease (CKD) have impaired renal 1-alpha-hydroxylation.

In mild to moderate CKD, colecalciferol may be used to correct deficiency, but serum calcium and phosphate should be monitored.

In advanced CKD (stages 4 and 5), active vitamin D analogues such as alfacalcidol or calcitriol are generally required and specialist nephrology guidance should be followed.

Drug interactions

Thiazide and thiazide-like diuretics (such as bendroflumethiazide and indapamide) reduce urinary calcium excretion and may increase the risk of hypercalcaemia when combined with vitamin D.

Cardiac glycosides (such as digoxin) have an increased risk of toxicity in the presence of hypercalcaemia.

Certain anticonvulsants (phenytoin, carbamazepine, phenobarbital) and rifampicin induce hepatic enzymes that accelerate vitamin D metabolism, potentially reducing its effectiveness.

Orlistat and cholestyramine may impair fat absorption and reduce vitamin D uptake. Inform your prescriber of all medications, supplements, and herbal products you take.

Pregnancy and breastfeeding

Vitamin D supplementation at 400 IU daily is recommended for all pregnant and breastfeeding women in the UK by NICE and SACN.

Higher doses for treating deficiency during pregnancy should be used under clinical supervision.

Vitamin D is excreted in breast milk in small amounts, and supplementation at recommended doses is considered safe during breastfeeding.

Healthy Start vitamins, which contain 400 IU of vitamin D, are available free of charge to eligible women in England.

How to get a Pro D3 prescription in the UK

Lower-strength vitamin D supplements (up to 1000 IU) are available without a prescription from pharmacies, supermarkets, and health food shops.

Higher-strength formulations of Pro D3, such as the 20,000 IU capsule used for loading dose treatment, are classified as prescription-only medicines (POM) in the UK and require a prescription from a GP, nurse prescriber, or authorised online prescriber registered with the General Pharmaceutical Council (GPhC).

Your GP can test your vitamin D levels with a simple blood test.

If deficiency is confirmed, a prescription for Pro D3 or another colecalciferol product will be issued alongside dietary and lifestyle advice.

The standard NHS prescription charge in England is currently 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.

Repeat prescriptions for ongoing maintenance therapy can be arranged through your GP surgery or online prescribing service.

Lifestyle advice for maintaining vitamin D levels

While supplementation is the most reliable way to correct and prevent deficiency, the following lifestyle measures also support adequate vitamin D status.

During spring and summer (April to September), aim for short periods of sun exposure (approximately 10 to 15 minutes) to the forearms, hands, or lower legs around the middle of the day without sunscreen, before covering up or applying protection to avoid sunburn.

Dietary sources of vitamin D include oily fish (salmon, mackerel, sardines, herring), cod liver oil, egg yolks, fortified cereals, fortified dairy and plant-based milks, and fortified spreads.

However, it is difficult to obtain sufficient vitamin D from diet alone, and supplementation remains the most practical strategy for most people in the UK.

When to seek urgent medical advice

Contact your GP or NHS 111 if you develop symptoms suggestive of hypercalcaemia (persistent nausea, excessive thirst, frequent urination, confusion, or muscle weakness) while taking Pro D3.

Seek emergency care by calling 999 or attending A&E if you experience signs of a severe allergic reaction such as throat swelling, facial swelling, or difficulty breathing.

Report any suspected adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .

Sources

• Pro D3 20,000 IU Capsules, Summary of Product Characteristics (EMC)
• Colecalciferol, British National Formulary (BNF)
• NICE CKS: Vitamin D deficiency in adults
• SACN vitamin D and health report (2016)
• Vitamin D, NHS
• MHRA Yellow Card Scheme